Location of Repository

The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

By Stephen Douglass, Atul Goyal and Renato V. Iozzo

Abstract

During tumor growth and angiogenesis there is a dynamic remodeling of tissue architecture often accompanied by the release of extracellular matrix constituents full of biological activity. One of the key constituents of the tumor microenvironment is the large heparan sulfate proteoglycan perlecan. This proteoglycan, strategically located at cell surfaces and within basement membranes, is a well-defined pro-angiogenic molecule when intact. However, when partially processed by proteases released during cancer remodeling and invasion, the C-terminal fragment of perlecan, known as endorepellin, has opposite effects than its parent molecule. Endorepellin is a potent inhibitor of angiogenesis by exerting a dual receptor antagonism by simultaneously engaging VEGFR2 and α2β1 integrin. Signaling through the α2β1 integrin leads to actin disassembly and block of endothelial cell migration, necessary for capillary morphogenesis. Signaling through the VEGFR2 induces dephosphorylation of the receptor via activation of SHP-1 and suppression of downstream proangiogenic effectors, especially attenuating VEGFA expression. A novel and emerging role of endorepellin is its ability to evoke autophagy by activating Peg3 and various canonical autophagic markers. This effect is specific for endothelial cells as these are the primary cells expressing both VEGFR2 and α2β1 integrin. Thus, an endogenous fragment of a ubiquitous proteoglycan can regulate both angiogenesis and autophagy through a dual receptor antagonism. The biological properties of this natural endogenous protein place endorepellin as a potential therapeutic agent against cancer or diseases where angiogenesis is prominent

Topics: Animals, Autophagy, Cell Movement, Endothelial Cells, Heparan Sulfate Proteoglycans, Humans, Neovascularization, Physiologic, Neovascularization, Physiologic, Medical Cell Biology, Medical Pathology, Medicine and Health Sciences
Publisher: Jefferson Digital Commons
Year: 2015
OAI identifier: oai:jdc.jefferson.edu:pacbfp-1206

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.